Cargando…
Phosphoinositide 3-kinase signaling is critical for ErbB3-driven breast cancer cell motility and metastasis
Many malignancies show increased expression of the EGF receptor family member ErbB3 (HER3). ErbB3 binds beta-1 (HRGβ1), and forms a heterodimer with other ErbB family members, such as ErbB2 (HER2) or EGFR (HER1), enhancing phosphorylation of specific C terminal tyrosine residues and activation of do...
Autores principales: | Smirnova, Tatiana, Zhou, Zhen Ni, Flinn, Rory J., Wyckoff, Jeffrey, Boimel, Pamela J., Pozzuto, Maria, Coniglio, Salvatore J., Backer, Jonathan M., Bresnick, Anne R., Condeelis, John S., Hynes, Nancy E., Segall, Jeffrey E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3469325/ https://www.ncbi.nlm.nih.gov/pubmed/21725367 http://dx.doi.org/10.1038/onc.2011.275 |
Ejemplares similares
-
Contribution of CXCL12 secretion to invasion of breast cancer cells
por: Boimel, Pamela J, et al.
Publicado: (2012) -
The ErbB receptor tyrosine kinases and their roles in cancer
por: Hynes, NE
Publicado: (2003) -
Proliferation of Colorectal Cancer Is Promoted by Two Signaling Transduction Expression Patterns: ErbB2/ErbB3/AKT and MET/ErbB3/MAPK
por: Yao, Yong-Liang, et al.
Publicado: (2013) -
Endocrine resistance in breast cancer: new roles for ErbB3 and ErbB4
por: Sutherland, Robert L
Publicado: (2011) -
ErbB activation signatures as potential biomarkers for anti-ErbB3 treatment in HNSCC
por: Alvarado, Diego, et al.
Publicado: (2017)